Fecha de publicación: 14/01/2025 Fuente: FierceBiotech The release name-checked UB-VV400, an off-the-shelf, multidomain fusion protein surface-engineered lentiviral vector designed to generate CD22-directed CAR-T cells within a patient’s body.